Latest From Biotech Now

BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders

Ernst & Young

The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the state of the biotech industry, Beyond Borders, was buoyed by positive trends outlined in the report that show despite the overall lingering uneasiness in the economy, biotech is continuing its growth momentum. The Super Session at the 2012 BIO International Convention was moderated by members of Ernst & Young’s life sciences leadership team: Glen Giovannetti, Gautam Jaggi and Sanjeev Wadhwa; Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Prior User Rights and Trade Secrets

Research

By Joe Allen, President, Allen and Associates One theme of the day is the cloud of uncertainity overhanging the US patent system. This was underscored in the Prior User Rights and Trade Secrets session at the 2012 BIO International Convention as well. The new prior user rights defense which came into effect with enactment of the America Invents Act (AIA) was very differently viewed by the small biotech company perspective given by Mary Ann Dillahunty (Oncolytics Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

BIO Official Blogger Roundup

Official Blogger

Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Enterprise, Advanced Education, and Stephen Khan, Genome Alberta My PET Bottle, Genome Alberta Research Partnerships Catalyze Economic Growth, LillyPad BIO 2012: Patients and PDUFA, Campaign for Modern Medicine Scientific American Worldview 4th edition now available #bio2012, Biotech Blog BIO 2012 Day 2: Justices Ponder Hot Tubbing, Patent Baristas Docs at BIO: IP Challenges to Personalized Medicine & Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Recent Developments in Patentability: Prometheus and Myriad

supreme-court

By Joe Allen, President, Allen and Associates Recent Developments in Patentability: Prometheus and Myriad at the 2012 BIO International Convention was a very lively panel discussion on two cases that have set the life science industry on edge. The discussion presented an appropriate diversity of views as experts struggle with how broadly these cases should be interpreted. Briefly, the unanimous decision by the Supreme Court overtuning a decision upholding the Prometheus patents by the Court Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Official Blogger Roundup

Official Blogger

Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Denmark leads the world in its pro-research attitude #bio2012, Biotech Blog Bioentrepreneurship Bootcamp signing at #bio2012, Biotech Blog Welcome to BIO 2012!, Campaign for Modern Medicine Greetings from BIO 2012!, The Cross-Border Biotech Blog BIORadio Lands in Boston, Genomics Blog Kicking off #BIO2012, LillyPad Research Partnerships Catalyze Economic Growth, LillyPad The BIO Official Bloggers Take Boston, Patent Baristas BIO Day 1: China, IP and Savings Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,